323 related articles for article (PubMed ID: 17927302)
1. Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy.
Shankar SM; Nania JJ
Paediatr Drugs; 2007; 9(5):301-9. PubMed ID: 17927302
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia.
Madden RM; Pui CH; Hughes WT; Flynn PM; Leung W
Cancer; 2007 Apr; 109(8):1654-8. PubMed ID: 17345613
[TBL] [Abstract][Full Text] [Related]
4. Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia.
Agrawal AK; Chang PP; Feusner J
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e1-4. PubMed ID: 21102354
[TBL] [Abstract][Full Text] [Related]
5. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
Simonds RJ; Hughes WT; Feinberg J; Navin TR
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S44-8. PubMed ID: 8547511
[TBL] [Abstract][Full Text] [Related]
6. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.
Kim SY; Dabb AA; Glenn DJ; Snyder KM; Chuk MK; Loeb DM
Pediatr Blood Cancer; 2008 Apr; 50(4):779-83. PubMed ID: 17635000
[TBL] [Abstract][Full Text] [Related]
7. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
Evans RA; Clifford TM; Tang S; Au T; Fugit AM
Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia.
Zar HJ; Alvarez-Martinez MJ; Harrison A; Meshnick SR
Clin Infect Dis; 2004 Oct; 39(7):1047-51. PubMed ID: 15472859
[TBL] [Abstract][Full Text] [Related]
11. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of caspofungin, a 1,3-β-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats.
Sun P; Tong Z
Med Mycol; 2014 Nov; 52(8):798-803. PubMed ID: 25288652
[TBL] [Abstract][Full Text] [Related]
13. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A38-49. PubMed ID: 11577363
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
Prosty C; Katergi K; Sorin M; Rjeily MB; Butler-Laporte G; McDonald EG; Lee TC
Clin Microbiol Infect; 2024 Jul; 30(7):866-876. PubMed ID: 38583518
[TBL] [Abstract][Full Text] [Related]
15. No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kato S; Kasahara S; Iseki T; Tojo A; Asano S
Transpl Infect Dis; 2008 Oct; 10(5):303-7. PubMed ID: 18564982
[TBL] [Abstract][Full Text] [Related]
16. Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation.
Lu YM; Lee YT; Chang HC; Yang HS; Chang CY; Huang CM; Wei J
Transplant Proc; 2017 Oct; 49(8):1893-1898. PubMed ID: 28923644
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis pneumonia in children receiving chemotherapy.
Prasad P; Nania JJ; Shankar SM
Pediatr Blood Cancer; 2008 Apr; 50(4):896-8. PubMed ID: 17458875
[TBL] [Abstract][Full Text] [Related]
18. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
19. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review.
Hughes WT
Clin Infect Dis; 1998 Jul; 27(1):191-204. PubMed ID: 9675476
[TBL] [Abstract][Full Text] [Related]
20. The influence of PCP prophylaxis on bacteriuria incidence and resistance development to trimethoprim/sulfamethoxazole in HIV-infected patients.
van Dooyeweert DA; Schneider MM; Borleffs JC; Hoepelman AI
Neth J Med; 1996 Dec; 49(6):225-7. PubMed ID: 8990860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]